A naturally DNase-free CRISPR-Cas12c enzyme silences gene expression
Preprint
Abstract
SUMMARY: Used widely for genome editing in human cells, plants and animals, CRISPR-Cas enzymes including Cas9 and Cas12 provide RNA-guided immunity to microbes by targeting foreign DNA sequences for cleavage. We show here that the native activity of CRISPR-Cas12c protects bacteria from phage infection by binding to DNA targets without cleaving them, revealing that antiviral interference can be accomplished without chemical attack on the invader or general metabolic disruption in the host. Biochemical experiments demonstrate that Cas12c is a site-specific ribonuclease capable of generating mature CRISPR RNAs (crRNAs) from precursor transcripts. Furthermore, we find that crRNA maturation is essential for Cas12c-mediated DNA targeting. Surprisingly, however, these crRNAs direct double-stranded DNA binding by Cas12c using a mechanism that precludes DNA cutting. Cas12c’s RNA-guided DNA binding activity enables robust transcriptional repression of fluorescent reporter proteins in cells. Furthermore, this naturally DNase-free Cas12c enzyme can protect bacteria from lytic bacteriophage infection when targeting an essential phage gene. Together these results show that Cas12c employs targeted DNA binding to provide anti-viral immunity in bacteria, providing a native DNase-free pathway for transient antiviral immunity.Keywords
All Related Versions
- Published version: Molecular Cell, 82 (11), 2148.
This publication has 46 references indexed in Scilit:
- Consequences of Cas9 cleavage in the chromosome ofEscherichia coliNucleic Acids Research, 2016
- Structures of a CRISPR-Cas9 R-loop complex primed for DNA cleavageScience, 2016
- Discovery and Functional Characterization of Diverse Class 2 CRISPR-Cas SystemsMolecular Cell, 2015
- The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systemsRNA Biology, 2013
- Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene ExpressionCell, 2013
- CRISPR RNA maturation by trans-encoded small RNA and host factor RNase IIINature, 2011
- Determination of cell fate selection during phage lambda infectionProceedings of the National Academy of Sciences, 2008
- CRISPR Provides Acquired Resistance Against Viruses in ProkaryotesScience, 2007
- Recombining the structures of HIV integrase, RuvC and RNase HStructure, 1995
- Mechanism of action of the cro protein of bacteriophage lambda.Proceedings of the National Academy of Sciences, 1978